Memory Inhibition and Delayed Onset Post-traumatic Stress Disorder in Older Subjects

NCT ID: NCT03897855

Last Updated: 2021-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2021-03-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the elderly, we can see a post-traumatic syndrome associated with an event that occurred before old age that had not previously manifested or not fully manifested.

This little-known pathology and notable psychiatric co-morbidities (depression, anxiety) can take in elderly subjects different masks that interfere with diagnosis and treatment.

The data in the literature suggest that this Post-Traumatic Stress Disorder with Delayed Expression (TSPT-R) may be related to a deficiency of the executive functions of inhibition, and more particularly a deficit of mental memory inhibition and therefore the removal of unwanted memories.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Stress Disorder in Old Age

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient (TSPT-R)

Post Traumatic Stress Disorder

Group Type OTHER

Post Traumatic Stress Disorder

Intervention Type OTHER

The test "Think / No-Think"

control

No Post Traumatic Stress Disorder

Group Type EXPERIMENTAL

Post Traumatic Stress Disorder

Intervention Type OTHER

The test "Think / No-Think"

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Post Traumatic Stress Disorder

The test "Think / No-Think"

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Regarding the constitution of the group patient (TSPT-R):

* Subjects 65 years of age or older
* Clinical diagnosis of delayed-onset PTSD according to DSM-5 criteria after 65 years
* The traumatic event must have taken place at the latest before 65 years
* Affiliated person or beneficiary of a social security scheme.
* Written consent before any examination required by research)

Regarding the constitution of the control group:

* Subjects 65 years of age or older
* No diagnosis of PTSD (delayed or not) or history of PTSD (delayed or not)
* Affiliated person or beneficiary of a social security scheme.
* Written consent before any examination required by the research).

Exclusion Criteria

* For both groups:
* Acute or chronic cognitive impairment known
* GRECO MMSE pathological score less than or equal to the pathological threshold weighted according to level of education and age, namely:

* 22 if no diploma
* 23 if certificate of study
* 25 if patent
* 26 if bin or more
* Remove one point at each threshold if age\> 80 years
* Sensory or motor disorder preventing the passing of different tests
* Psychotic disorder
* Mood disorder in decompensation (for depression, HAD-D score equal to or greater than 11)
* Disorder of the use of a moderate or severe substance (except tobacco).
* Patients under guardianship or curatorship.
Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier de Niort

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominique LEGER, Doctor

Role: STUDY_DIRECTOR

Centre Hospitalier de Niort

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier de Niort

Niort, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CH-NIORT-2018-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cognitive Therapy for PTSD in Addiction Treatment
NCT00685451 COMPLETED PHASE1/PHASE2